Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of common antihypertensive drugs on aldosterone–renin ratio
ChiCTR2200056129Phase 4Recruiting
- Sponsor
- Fuwai Central China Cardiovascular Hospital
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of carvedilol in hypertension (HTN) (4 arms), sponsored by Fuwai Central China Cardiovascular Hospital. Primary endpoints: plasma aldosterone concentration, plasma renin concentration and 1 more. Started Oct 2021; status: recruiting.
02
Drugs
carvedilol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR2200056129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056129.